Rockefeller Capital Management L.P. Buys 1,420 Shares of Waters Corporation $WAT

Rockefeller Capital Management L.P. boosted its stake in Waters Corporation (NYSE:WAT) by 106.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,751 shares of the medical instruments supplier’s stock after buying an additional 1,420 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Waters were worth $1,045,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the stock. SG Americas Securities LLC boosted its stake in shares of Waters by 543.8% in the 4th quarter. SG Americas Securities LLC now owns 37,244 shares of the medical instruments supplier’s stock valued at $14,146,000 after purchasing an additional 31,459 shares in the last quarter. Mackenzie Financial Corp increased its position in shares of Waters by 12.2% during the 3rd quarter. Mackenzie Financial Corp now owns 231,852 shares of the medical instruments supplier’s stock worth $69,512,000 after purchasing an additional 25,182 shares in the last quarter. Banque Cantonale Vaudoise increased its position in shares of Waters by 329.0% during the 4th quarter. Banque Cantonale Vaudoise now owns 4,294 shares of the medical instruments supplier’s stock worth $1,631,000 after purchasing an additional 3,293 shares in the last quarter. Nordea Investment Management AB lifted its holdings in Waters by 15.8% during the 4th quarter. Nordea Investment Management AB now owns 13,550 shares of the medical instruments supplier’s stock valued at $5,177,000 after purchasing an additional 1,848 shares during the last quarter. Finally, Graybill Wealth Management LTD. acquired a new position in Waters in the third quarter valued at about $2,591,000. 94.01% of the stock is currently owned by institutional investors.

Waters Stock Up 0.1%

Shares of Waters stock opened at $378.62 on Friday. The business has a fifty day simple moving average of $350.65 and a 200 day simple moving average of $346.80. The stock has a market cap of $37.18 billion, a PE ratio of 48.11, a price-to-earnings-growth ratio of 2.29 and a beta of 1.20. The company has a quick ratio of 1.13, a current ratio of 1.79 and a debt-to-equity ratio of 0.32. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15.

Waters (NYSE:WAT) last released its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share for the quarter, beating the consensus estimate of $2.31 by $0.39. Waters had a return on equity of 15.60% and a net margin of 11.91%.The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.20 billion. During the same quarter in the prior year, the firm posted $2.25 earnings per share. The company’s quarterly revenue was up 91.4% on a year-over-year basis. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Research analysts predict that Waters Corporation will post 14.51 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on WAT shares. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $350.00 price target on shares of Waters in a report on Thursday, May 7th. TD Cowen raised their target price on Waters from $345.00 to $385.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Barclays increased their price objective on shares of Waters from $400.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Weiss Ratings restated a “hold (c)” rating on shares of Waters in a research report on Monday, April 20th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Waters from $330.00 to $345.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Four analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $396.68.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.